KLA Corporation has now reported, and the market's verdict is in: a 6% single-day drop and a 12% weekly loss, with the Street scrambling to reprice a stock that entered earnings carrying one of its heaviest short burdens in years.
The short position has moved sharply in the days surrounding the print. Heading into the July 28 report, shorts held roughly 20.9% of the free float — still elevated, but down 18% from the prior week's peak near 25%. The step-down is meaningful. From mid-July through July 22, short interest held in a tight band around 33 million shares. Then, in a single session on July 23, it dropped nearly 4 million shares — suggesting some shorts took profits or closed positions into the event rather than through it. Cost to borrow, still negligible at 0.52%, tells you this was a tactical unwind, not a forced close. Availability remains extremely loose — multiple thousands of percent of outstanding short interest — so there is no mechanical squeeze dynamic at work. The borrow market is calm even as the position is large.
Options traders had spent the past two weeks demanding downside protection at an accelerating rate. The put/call ratio closed Tuesday at 1.65, 1.57 standard deviations above its 20-day average of 1.45. That is a consistent theme from the previous notes: the PCR has been grinding higher since mid-July, rising from around 1.38 on July 10 to current levels. What's notable now is that the move was right — the hedges paid off. Whether those positions have been unwound or rolled forward into the next quarter will shape the near-term tone.
The analyst community has delivered its own reset overnight. Today's moves split in two directions. Susquehanna cut its target from $275 to $215 while holding Neutral — a 22% reduction. Wells Fargo trimmed from $305 to $245, staying Overweight, and Deutsche Bank cut from $220 to $195 at Hold. These are not marginal adjustments; they reflect a meaningful reassessment of the multiple. Against that, JP Morgan's Harlan Sur raised his target from $200 to $238 at Overweight — one of the more constructive reads from a bellwether — and Cantor Fitzgerald held firm at $325. The mean consensus target now rests near $229, implying roughly 20% upside from Wednesday's $190.80 close. The spread between the most bearish ($180 from RBC) and most bullish ($325 from Cantor) is unusually wide, reflecting genuine disagreement about whether the post-earnings derating is done or still in progress. The bear case centres on export control exposure in China, slowing HighNA EUV adoption, and a premium multiple that leaves little room for revenue misses. Bulls point to KLA's process control dominance, its TSMC and Samsung relationships, and services growth as durable floor.
The valuation reset is material. The P/E multiple has compressed to 32.7x, down more than 30 points over the past month. EV/EBITDA has fallen to 27.5x, off 10 points in the same window. These are not incremental moves — they represent a genuine derating, not just the stock tracking the sector lower. For context, the whole semiconductor equipment group has had a rough week: AMAT fell 7.8% on the day and 15.6% on the week; LRCX dropped 7.5% and 16.3%; UCTT led the carnage at nearly 11% daily and 26% weekly. KLAC's 12% weekly decline sits roughly in the middle of that peer distribution — neither the worst nor the most resilient name in the group.
The insider picture adds a quietly uncomfortable note. CEO Richard Wallace sold 45,850 shares on June 30 at $278.39, a transaction worth $12.8 million. CFO Bren Higgins sold an additional $15.9 million across two dates in late June and early July. All of these transactions cleared at prices well above where the stock trades today — $190.80 — suggesting those sales were well-timed relative to the subsequent slide, though insider sell programmes are typically pre-scheduled. The 90-day net insider position is a seller of $64.4 million in value across the executive suite.
The next earnings date is October 30. Between now and then, the key variable is whether the analyst community's target compression stabilises — or whether the wide dispersion between RBC's $180 and Cantor's $325 starts to narrow in one direction as China export data and foundry capex guidance become clearer through the quarter.
See the live data behind this article on ORTEX.
Open KLAC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
